CNS Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNSP and other ETFs, options, and stocks.

About CNSP

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. 

CEO
Rami Levin
CEORami Levin
Employees
8
Employees8
Headquarters
Houston, Texas
HeadquartersHouston, Texas
Founded
2017
Founded2017
Employees
8
Employees8

CNSP Key Statistics

Market cap
7.69M
Market cap7.69M
Price-Earnings ratio
-0.17
Price-Earnings ratio-0.17
Dividend yield
Dividend yield
Average volume
110.34K
Average volume110.34K
High today
$5.00
High today$5.00
Low today
$5.00
Low today$5.00
Open price
$4.98
Open price$4.98
Volume
427.00
Volume427.00
52 Week high
$15.73
52 Week high$15.73
52 Week low
$1.90
52 Week low$1.90

Stock Snapshot

The current CNS Pharmaceuticals(CNSP) stock price is $5.00, with a market capitalization of 7.69M. The stock trades at a price-to-earnings (P/E) ratio of -0.17.

During the trading session on 2026-05-21, CNS Pharmaceuticals(CNSP) shares reached a daily high of $5.00 and a low of $5.00. At a current price of $5.00, the stock is 0.0% higher than the low and still 0.0% under the high.

Trading activity shows a volume of 427, compared to an average daily volume of 110.34K.

The stock's 52-week range extends from a low of $1.90 to a high of $15.73.

The stock's 52-week range extends from a low of $1.90 to a high of $15.73.

CNSP News

TipRanks 10h
Insider Boost: CNS Pharmaceuticals Director Quietly Ramps Up His Stake

New insider activity at CNS Pharmaceuticals ( (CNSP) ) has taken place on May 20, 2026. Start a conversation with TipRanks’ trusted, data-backed investment int...

Investing.com 19h
CNS Pharmaceuticals director Faith L. Charles buys $34,001 in stock - Investing.com

...

CNS Pharmaceuticals director Faith L. Charles buys $34,001 in stock - Investing.com
TipRanks 2d
CNS Pharmaceuticals files to sell 9.79M shares of common stock for holders

16:57 EDT CNS Pharmaceuticals (CNSP) files to sell 9.79M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, mark...

More CNSP News

TipRanks 7d
CNS Pharmaceuticals reports Q1 EPS ($7.30) vs. ($18.93) last year

“We believe CNS Pharmaceuticals (CNSP) has entered a transformational new phase defined by strategic clarity, financial strength and disciplined execution,” sai...

People also own

Based on the portfolios of people who own CNSP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.